SI-BONE Statistics
Total Valuation
SI-BONE has a market cap or net worth of $665.66 million. The enterprise value is $557.05 million.
Important Dates
The next confirmed earnings date is Monday, November 10, 2025, after market close.
| Earnings Date | Nov 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SI-BONE has 43.14 million shares outstanding. The number of shares has increased by 3.42% in one year.
| Current Share Class | 43.14M |
| Shares Outstanding | 43.14M |
| Shares Change (YoY) | +3.42% |
| Shares Change (QoQ) | +1.06% |
| Owned by Insiders (%) | 3.04% |
| Owned by Institutions (%) | 91.05% |
| Float | 39.24M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.51 |
| Forward PS | 3.10 |
| PB Ratio | 3.90 |
| P/TBV Ratio | 3.91 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.01 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.38, with a Debt / Equity ratio of 0.22.
| Current Ratio | 8.38 |
| Quick Ratio | 6.88 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.18 |
Financial Efficiency
Return on equity (ROE) is -14.18% and return on invested capital (ROIC) is -8.41%.
| Return on Equity (ROE) | -14.18% |
| Return on Assets (ROA) | -7.59% |
| Return on Invested Capital (ROIC) | -8.41% |
| Return on Capital Employed (ROCE) | -13.39% |
| Revenue Per Employee | $530,837 |
| Profits Per Employee | -$68,092 |
| Employee Count | 349 |
| Asset Turnover | 0.81 |
| Inventory Turnover | 1.33 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +18.88% in the last 52 weeks. The beta is 0.84, so SI-BONE's price volatility has been lower than the market average.
| Beta (5Y) | 0.84 |
| 52-Week Price Change | +18.88% |
| 50-Day Moving Average | 15.35 |
| 200-Day Moving Average | 16.27 |
| Relative Strength Index (RSI) | 53.76 |
| Average Volume (20 Days) | 427,174 |
Short Selling Information
The latest short interest is 2.41 million, so 5.58% of the outstanding shares have been sold short.
| Short Interest | 2.41M |
| Short Previous Month | 2.11M |
| Short % of Shares Out | 5.58% |
| Short % of Float | 6.13% |
| Short Ratio (days to cover) | 6.07 |
Income Statement
In the last 12 months, SI-BONE had revenue of $185.26 million and -$23.76 million in losses. Loss per share was -$0.56.
| Revenue | 185.26M |
| Gross Profit | 147.18M |
| Operating Income | -27.61M |
| Pretax Income | -23.76M |
| Net Income | -23.76M |
| EBITDA | -22.67M |
| EBIT | -27.61M |
| Loss Per Share | -$0.56 |
Full Income StatementBalance Sheet
The company has $145.54 million in cash and $36.93 million in debt, giving a net cash position of $108.61 million or $2.52 per share.
| Cash & Cash Equivalents | 145.54M |
| Total Debt | 36.93M |
| Net Cash | 108.61M |
| Net Cash Per Share | $2.52 |
| Equity (Book Value) | 170.34M |
| Book Value Per Share | 3.96 |
| Working Capital | 182.70M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$3.26 million and capital expenditures -$9.47 million, giving a free cash flow of -$12.73 million.
| Operating Cash Flow | -3.26M |
| Capital Expenditures | -9.47M |
| Free Cash Flow | -12.73M |
| FCF Per Share | -$0.30 |
Full Cash Flow StatementMargins
Gross margin is 79.45%, with operating and profit margins of -14.90% and -12.83%.
| Gross Margin | 79.45% |
| Operating Margin | -14.90% |
| Pretax Margin | -12.83% |
| Profit Margin | -12.83% |
| EBITDA Margin | -12.24% |
| EBIT Margin | -14.90% |
| FCF Margin | n/a |
Dividends & Yields
SI-BONE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.42% |
| Shareholder Yield | -3.42% |
| Earnings Yield | -3.57% |
| FCF Yield | -1.91% |
Analyst Forecast
The average price target for SI-BONE is $24.60, which is 59.43% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $24.60 |
| Price Target Difference | 59.43% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SI-BONE has an Altman Z-Score of 5.03 and a Piotroski F-Score of 4.
| Altman Z-Score | 5.03 |
| Piotroski F-Score | 4 |
